ZACKS
Search documents
Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?
ZACKS· 2026-02-18 15:45
Core Insights - Tempus AI, Inc. (TEM) is set to report its fourth-quarter 2025 results on February 24, with expectations of an 82.8% year-over-year revenue increase to $366.8 million [2][7] - The company reported an adjusted loss of 11 cents per share in the last quarter, which was better than the Zacks Consensus Estimate of a loss of 16 cents [1] - Tempus has seen a share price decline of 32.9% in the fourth quarter due to macroeconomic challenges, despite strong momentum from strategic acquisitions and product launches [3][7] Financial Performance - The Zacks Consensus Estimate for loss per share has remained unchanged at 2 cents over the past 30 days [2] - The company's earnings estimate revision trend shows consistent expectations for the current quarter and the next, with losses projected at -0.02 for Q4 and -0.13 for Q1 2026 [3] - In the previous quarter, Tempus achieved a gross profit improvement of 98.4% year-over-year, and adjusted EBITDA turned positive, indicating progress towards profitability [14] Market Position and Competitive Landscape - Tempus trades at a forward price-to-sales (P/S) ratio of 5.82X, which is above the industry average of 5.66X and higher than competitors like 10x Genomics (3.83X) and SOPHiA GENETICS (3.69X) [16] - The Zacks Medical Info Systems industry experienced a loss of 21.6% during the same period, while the S&P 500 gained 3.3% [4] Strategic Developments - Recent collaborations include a multi-year partnership with Whitehawk Therapeutics for oncology treatments and a selection by the Advanced Research Projects Agency for Health to provide testing services [8] - The Genomics segment is expected to show improvement due to growth in oncology testing and hereditary sequencing, while the Data and Services business is likely to benefit from strong demand for proprietary data licensing and AI solutions [9][10] - Tempus has enhanced its capabilities through the acquisition of Paige, an AI leader in digital pathology, and expanded its collaboration with Northwestern Medicine to integrate AI into clinical workflows [12] Future Outlook - The AI market is anticipated to grow rapidly, positioning Tempus to capitalize on emerging opportunities in healthcare [17] - Despite recent upsides, the company's premium valuation and lack of near-term profitability may limit immediate gains [18]
CNH Q4 Earnings Beat Expectations, Revenues Increase Y/Y
ZACKS· 2026-02-18 15:45
Core Insights - CNH Industrial reported fourth-quarter 2025 adjusted earnings per share (EPS) of 19 cents, an increase from 15 cents in the prior-year quarter, surpassing the Zacks Consensus Estimate of 11 cents [1] - Consolidated revenues rose 5.8% year over year to $5.16 billion, exceeding the Zacks Consensus Estimate of $5.02 billion [1] Segmental Performance - Agriculture segment net sales increased 5% year over year to $3.6 billion, driven by favorable price realization and positive foreign exchange impacts, beating the estimate of $3.41 billion [2] - Adjusted EBIT for the Agriculture segment was $233 million, down 5% year over year due to lower volumes and higher costs, but still above the estimate of $172.6 million; adjusted EBIT margin decreased to 6.5% from 7.2% [2] - Construction segment sales rose 19% year over year to $853 million, attributed to higher volume and favorable price realization in North America, surpassing the estimate of $810.3 million [3] - Adjusted EBIT for the Construction segment was $5 million, down 72% year over year due to increased production costs, with adjusted EBIT margin decreasing to 0.6% from 2.5% [3] - Financial Services segment revenues fell 6% to $700 million, missing the estimate of $770.4 million, while net income increased from $92 million to $109 million year over year [4] Financial Details - As of December 31, 2025, CNH Industrial had cash and cash equivalents of $2.58 billion, down from $3.19 billion a year earlier [5] - Total debt was $26.76 billion, a slight decrease from $26.88 billion as of December 31, 2024 [5] - Net cash provided by operating activities was $945 million, compared to $1.69 billion in the prior year [5] - Free cash outflow from industrial activities was $817 million, slightly improved from $848 million in the fourth quarter of 2024 [5] 2026 Guidance - For 2026, Agriculture sales are expected to decrease and remain flat at 5% year over year, with adjusted EBIT margin projected between 4.5-5.5% [6] - Construction segment sales are expected to remain flat year over year, with adjusted EBIT margin anticipated in the range of 1-2% [6] - Free cash flow from industrial activities is expected to be between $150-$350 million, with adjusted EPS projected between 35 cents and 45 cents, down from 55 cents in 2025 [7] Zacks Rank & Key Picks - CNH currently holds a Zacks Rank 4 (Sell) [8] - Other better-ranked stocks in the industrial product space include Kawasaki Heavy Industries, Kennametal, and Proto Labs, each with a Zacks Rank 1 (Strong Buy) [10]
W.P. Carey Stock Up 12.1% in Three Months: Will the Trend Last?
ZACKS· 2026-02-18 15:45
Key Takeaways WPC shares gained 12.1% in three months, beating the industry growth of 7.4%.W.P. Carey posted Q4 2025 AFFO of $1.27, up 5% year over year on higher rents and investments.WPC holds 98% occupancy, a 12-year lease term and $2.2B liquidity to fund value-accretive deals.W.P. Carey (WPC) shares have rallied 12.1% over the past three months, outperforming the industry's upside of 7.4%.The company is poised to benefit from a high-quality, mission-critical, diversified portfolio of single-tenant, net- ...
Can Higher-Capacity HAMR Momentum Power Seagate's Long-Term Upside?
ZACKS· 2026-02-18 15:45
Core Insights - The demand for high-capacity, cost-efficient storage is surging due to the growth of cloud computing, generative AI, video streaming, and connected devices, with Seagate Technology Holdings plc (STX) leading the market through its Heat-Assisted Magnetic Recording (HAMR) technology [1][2] Group 1: Seagate's Technology and Market Position - Seagate began shipping its first commercial HAMR-based drives in 2023-2024, targeting large hyperscale cloud and enterprise customers, and has accelerated the ramp of these drives to meet AI-driven data storage needs [2] - In 2025, Seagate delivered over 1.5 million HAMR units and secured qualifications with all major U.S. cloud service providers, with global approvals expected by mid-2026 [3] - Seagate's nearline capacity is fully booked through 2026, supported by long-term cloud agreements, providing demand visibility into 2027 and early discussions for 2028 [3] Group 2: Financial Performance and Projections - The ramp of HAMR technology is expected to enhance Seagate's financial profile by expanding margins and improving cost efficiency, with fiscal 2026 capital spending projected to remain within 4-6% of revenues [4] - For the fiscal third quarter, Seagate anticipates revenues of $2.9 billion, representing a 34% increase at the midpoint [4][8] - Seagate's shares have increased by 303.8% over the past year, outperforming the Computer Integrated Systems industry's growth of 84.3% [7] Group 3: Competitive Landscape - Western Digital Corporation (WDC) is advancing its own storage technologies, including HAMR and ePMR, and expects fiscal third-quarter revenues of $3.2 billion, up 40% [5] - Micron Technology (MU) is capitalizing on the AI-driven memory and storage markets, with anticipated revenues of $18.7 billion in the fiscal second quarter [6] Group 4: Valuation and Earnings Estimates - Seagate's shares are currently trading at a forward price/earnings ratio of 26.27X, higher than the industry's 16.24X [9] - The Zacks Consensus Estimate for Seagate's earnings for fiscal 2026 has been revised upward over the past 60 days, indicating positive market sentiment [10]
Why Air Products and Chemicals (APD) is a Top Growth Stock for the Long-Term
ZACKS· 2026-02-18 15:45
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Sty ...
Why Howmet (HWM) is a Top Growth Stock for the Long-Term
ZACKS· 2026-02-18 15:45
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style Sc ...
Valmont Industries (VMI) is a Top-Ranked Growth Stock: Should You Buy?
ZACKS· 2026-02-18 15:45
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as we ...
Innodata vs. BigBear.ai: Which AI Play Has More Upside Now?
ZACKS· 2026-02-18 15:42
Core Insights - The artificial intelligence boom has created distinct investment opportunities, with Innodata (INOD) and BigBear.ai (BBAI) representing different approaches to capitalize on this trend [1][2]. Company Overview - Innodata has positioned itself as a high-growth data engineering partner for Big Tech and AI model builders, acting as a "picks and shovels" enabler of generative AI [2]. - BigBear.ai focuses on mission-ready AI solutions for defense and intelligence, recently expanding its capabilities through acquisitions [2]. Financial Performance - Innodata reported third-quarter revenues of $62.6 million, a 20% increase year over year, with adjusted EBITDA of $16.2 million, and anticipates 45% or more revenue growth in 2025 [7][10]. - In contrast, BigBear.ai's third-quarter revenue declined 20% year over year to $33.1 million, with a gross margin decrease to 22.4% [8][10]. Growth Potential - Innodata's revenue for the first nine months of 2025 reached $179.3 million, up 61% year over year, driven by demand for high-quality data [9]. - The company has a potential revenue pipeline of approximately $68 million from new contracts, positioning it well for future growth [11]. - BigBear.ai's recent acquisition of Ask Sage for $250 million aims to enhance its secure AI capabilities, although operational performance remains under pressure [14][17]. Valuation Metrics - Innodata trades at a forward price-to-sales ratio of 4.39X, while BigBear.ai trades at 9.95X, despite BigBear's weaker growth trajectory and negative EBITDA [10][18]. - Innodata's lower valuation multiple aligns with its profitable growth profile and clearer earnings visibility [18]. Earnings Outlook - The consensus estimate for Innodata's 2026 earnings per share is $1.12, indicating a 27.8% growth from 2025, with revenues expected to rise 25.9% [21]. - BigBear.ai is projected to narrow its loss to 25 cents per share in 2026, with revenues expected to grow 30.2% [22]. Investment Considerations - Both companies are positioned to benefit from expanding AI budgets, particularly in generative AI and federal deployments [23]. - However, Innodata is seen as having a clearer path to sustained profitability and diversified growth drivers, making it a more compelling investment opportunity at current levels [24][25].
Should Investors Buy, Sell or Hold KROS Stock Ahead of Q4 Earnings?
ZACKS· 2026-02-18 15:42
Key Takeaways KROS is set to report Q4 results, with investors focused on pipeline progress over limited license revenues.Rinvatercept advanced in DMD with phase I data and orphan drug tag; phase II start planned for 2026.Takeda deal on elritercept triggered $10M milestone as phase III RENEW study dosed first patient.We expect investors to focus on pipeline updates when Keros Therapeutics (KROS) reports fourth-quarter results shortly. The Zacks Consensus Estimate for sales and loss per share is pegged at $6 ...
Is KTOS Stock a Smart Investment Option Before Q4 Earnings Release?
ZACKS· 2026-02-18 15:42
Core Viewpoint - Kratos Defense & Security Solutions (KTOS) is anticipated to report fourth-quarter 2025 results on February 23, with earnings expected to grow by 7.69% year-over-year and revenues projected to increase by 15.95% from the previous year [1][7]. Financial Estimates - The Zacks Consensus Estimate for earnings is set at 14 cents per share for Q4 2025, with a revenue estimate of $328.25 million [1][2]. - Year-over-year growth estimates for earnings and revenues are 7.69% and 15.95%, respectively [1][2]. - The earnings estimates for the current year (2025) and next year (2026) are $0.51 and $0.73 per share, indicating growth of 4.08% and 41.92% respectively [2]. Earnings Surprise History - Kratos has consistently beaten earnings estimates in the last four quarters, with an average surprise of 29.17% [3][4]. Growth Drivers - The company is expected to benefit from increased target drone production and expanded maintenance, repair, and overhaul (MRO) capacity [7][10]. - New facilities in the U.S. and Jerusalem are anticipated to enhance engine, microwave, and RF production, thereby improving efficiency and revenue [7][12][13]. Stock Performance - Over the past three months, KTOS stock has returned 30.9%, outperforming the industry growth of 16.1% [14]. - The stock is currently trading at a discount compared to its industry on a forward 12-month price-to-sales (P/S) basis [17]. Investment Thesis - Kratos is recognized as a leading provider of unmanned aerial target drones, with a strong reputation and technology that supports consistent contract wins and global expansion [20]. - The Valkyrie UAS is becoming a core platform in the U.S. Marine Corps' Collaborative Combat Aircraft program, enhancing cash flow visibility and long-term growth prospects [21]. Challenges - The company faces supply-chain challenges due to raw material shortages, which may impact operations [24].